Literature DB >> 2377175

Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study.

R Sporik1, S T Holgate, T A Platts-Mills, J J Cogswell.   

Abstract

BACKGROUND AND METHODS: Children with asthma commonly have positive skin tests for inhaled allergens, and in the United Kingdom the majority of older children with asthma are sensitized to the house-dust mite. In a cohort of British children at risk for allergic disease because of family history, we investigated prospectively from 1978 to 1989 the relation between exposure to the house-dust mite allergen (Der p I) and the development of sensitization and asthma.
RESULTS: Of the 67 children studied in 1989, 35 were atopic (positive skin tests), and 32 were nonatopic. Of the 17 with active asthma, 16 were atopic (P less than 0.005), all of whom were sensitized to the house-dust mite, as judged by positive skin tests and levels of specific IgE antibodies (P less than 0.001). For house-dust samples collected from the homes of 59 of the children in 1979 and from 65 homes in 1989, the geometric means for the highest Der p I exposure were, respectively, 16.1 and 16.8 micrograms per gram of sieved dust. There was a trend toward an increasing degree of sensitization at the age of 11 with greater exposure at the age of 1 (P = 0.062). All but one of the children with asthma at the age of 11 had been exposed at 1 year of age to more than 10 micrograms of Der p I per gram of dust; for this exposure, the relative risk of asthma was 4.8 (P = 0.05). The age at which the first episode of wheezing occurred was inversely related to the level of exposure at the age of 1 for all children (P = 0.015), but especially for the atopic children (r = -0.66, P = 0.001).
CONCLUSIONS: In addition to genetic factors, exposure in early childhood to house-dust mite allergens is an important determinant of the subsequent development of asthma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2377175     DOI: 10.1056/NEJM199008233230802

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  273 in total

Review 1.  Early life origins of asthma.

Authors:  J E Gern; R F Lemanske; W W Busse
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Immune mechanisms of childhood asthma.

Authors:  C E Donovan; P W Finn
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

3.  Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions.

Authors:  H Wan; H L Winton; C Soeller; E R Tovey; D C Gruenert; P J Thompson; G A Stewart; G W Taylor; D R Garrod; M B Cannell; C Robinson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

4.  Mite, cat, and cockroach exposure, allergen sensitisation, and asthma in children: a case-control study of three schools.

Authors:  R Sporik; S P Squillace; J M Ingram; G Rakes; R W Honsinger; T A Platts-Mills
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 5.  Is allergen exposure the major primary cause of asthma?

Authors:  N Pearce; J Douwes; R Beasley
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 6.  Prospects for preventing asthma.

Authors:  P J Helms; G Christie
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

7.  Glutaric aciduria and suspected child abuse.

Authors:  A A Morris; G F Hoffmann; E R Naughten; A A Monavari; J E Collins; J V Leonard
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

8.  An epidemiological study of the relative importance of damp housing in relation to adult health.

Authors:  J Evans; S Hyndman; S Stewart-Brown; D Smith; S Petersen
Journal:  J Epidemiol Community Health       Date:  2000-09       Impact factor: 3.710

9.  Horse allergy in children.

Authors:  G Roberts; G Lack
Journal:  BMJ       Date:  2000-07-29

Review 10.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.